Sanofi and Regeneron present more positive data for Dupixent product - Qoneqt

QONEQT in Sanofi

11-Oct-2022 06:24 AM

Sanofi and Regeneron present more positive data for Dupixent product

PARIS (Reuters) - Healthcare companies Sanofi (NASDAQ:SNY) and partner Regeneron (NASDAQ:REGN) presented on Tuesday more positive data for their Dupixent product.

The companies said new data showed that Dupixent showed a significant histological remission of eosinophilic esophagitis in children 1 to 11 years old.

Eosinophilic esophagitis is a chronic inflammatory disease that damages the esophagus and prevents it from working properly.
Source: NDTV
#Sanofi

0

0

₹0

Personal details

(Or)

Enter email address

Date of birth

Gender

Nationality

Identity verification

Face verification

Face preview

jhon